Dataset Information
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
Ontology highlight
ABSTRACT:
SUBMITTER: Galappaththy GN
PROVIDER: S-EPMC6532739 | biostudies-literature | 2013 Oct
REPOSITORIES: biostudies-literature
Publications
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
The Cochrane database of systematic reviews 20131026 10
<h4>Background</h4>Plasmodium vivax infections are an important contributor to the malaria burden worldwide. The World Health Organization recommends a 14-day course of primaquine (0.25 mg/kg/day, giving an adult dose of 15 mg/day) to eradicate the liver stage of the parasite and prevent relapse of the disease. Many people find a 14-day primaquine regimen difficult to complete, and there is a potential risk of haemolytic anaemia in people with glucose-6-phosphate-dehydrogenase enzyme (G6PD) defi ...[more]